January 24, 2018 / 2:21 PM / 8 months ago

BRIEF-CAS Group Delivers Letter To The Stockholders Of Aviragen

Jan 24 (Reuters) - Aviragen Therapeutics Inc:

* CAS GROUP DELIVERS LETTER TO THE STOCKHOLDERS OF AVIRAGEN

* CAS GROUP SAYS PROPOSED MERGER BETWEEN AVIRAGEN AND VAXART NOT IN BEST INTERESTS OF STOCKHOLDERS OF AVIRAGEN

* CAS GROUP - “BELIEVE VAXART’S TRUE VALUE IS LOWER THAN THAT INDICATED IN PROPOSED MERGER”

* CAS GROUP SAYS “‍BELIEVE VAXART’S TRUE VALUE IS LOWER THAN THAT INDICATED IN PROPOSED MERGER AND THAT VAXART IS NOT READY TO BE A PUBLIC COMPANY”​

* CAS GROUP - DIGIRAD CORP, EAST HILL MANAGEMENT, THOMAS CLAY (COLLECTIVELY CAS GROUP) OWN ABOUT 8.3 PERCENT OF OUTSTANDING AVIRAGEN SHARES

* CAS GROUP - HAS NOMINATED A SLATE OF DIRECTORS FOR AVIRAGEN’S BOARD Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below